EMA in last push to thrash out detail of data disclosure policy
This article was originally published in Scrip
Executive Summary
With June still firmly in its sights for the completion of its new policy on proactive publication of clinical trial data, the European Medicines Agency has announced that it will hold a final round of talks with key stakeholders in May to iron out any remaining issues.